Apoptosis and liver disease

Christian Rust, Gregory James Gores

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Based on the available formation, apoptosis is clearly playing an important role in the pathophysiology of human liver diseases. An increased rat of apoptosis involving many different mediators, such as Fas, TNF-alpha, TGF-beta 1, and members of the Bcl-2 family is contributing to the liver injury seen in a variety of diseases, including viral hepatitis, cholestatic disorders, and alcoholic liver disease. A reduction of apoptosis should therefore be beneficial in these diseases and the goal for future drug development. On the other hand, dysregulation of apoptotic processes protects malignant hepatocytes from cellular suicide. Specific induction of apoptosis might therefore be a new option for the prevention and treatment of HCC.

Original languageEnglish (US)
Pages (from-to)567-574
Number of pages8
JournalAmerican Journal of Medicine
Volume108
Issue number7
DOIs
StatePublished - May 2000

Fingerprint

Liver Diseases
Apoptosis
Transforming Growth Factor beta1
Alcoholic Liver Diseases
Virus Diseases
Suicide
Hepatitis
Hepatocytes
Tumor Necrosis Factor-alpha
Liver
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Apoptosis and liver disease. / Rust, Christian; Gores, Gregory James.

In: American Journal of Medicine, Vol. 108, No. 7, 05.2000, p. 567-574.

Research output: Contribution to journalArticle

Rust, Christian ; Gores, Gregory James. / Apoptosis and liver disease. In: American Journal of Medicine. 2000 ; Vol. 108, No. 7. pp. 567-574.
@article{b3bb7209823f41f5986736b174430187,
title = "Apoptosis and liver disease",
abstract = "Based on the available formation, apoptosis is clearly playing an important role in the pathophysiology of human liver diseases. An increased rat of apoptosis involving many different mediators, such as Fas, TNF-alpha, TGF-beta 1, and members of the Bcl-2 family is contributing to the liver injury seen in a variety of diseases, including viral hepatitis, cholestatic disorders, and alcoholic liver disease. A reduction of apoptosis should therefore be beneficial in these diseases and the goal for future drug development. On the other hand, dysregulation of apoptotic processes protects malignant hepatocytes from cellular suicide. Specific induction of apoptosis might therefore be a new option for the prevention and treatment of HCC.",
author = "Christian Rust and Gores, {Gregory James}",
year = "2000",
month = "5",
doi = "10.1016/S0002-9343(00)00370-3",
language = "English (US)",
volume = "108",
pages = "567--574",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Apoptosis and liver disease

AU - Rust, Christian

AU - Gores, Gregory James

PY - 2000/5

Y1 - 2000/5

N2 - Based on the available formation, apoptosis is clearly playing an important role in the pathophysiology of human liver diseases. An increased rat of apoptosis involving many different mediators, such as Fas, TNF-alpha, TGF-beta 1, and members of the Bcl-2 family is contributing to the liver injury seen in a variety of diseases, including viral hepatitis, cholestatic disorders, and alcoholic liver disease. A reduction of apoptosis should therefore be beneficial in these diseases and the goal for future drug development. On the other hand, dysregulation of apoptotic processes protects malignant hepatocytes from cellular suicide. Specific induction of apoptosis might therefore be a new option for the prevention and treatment of HCC.

AB - Based on the available formation, apoptosis is clearly playing an important role in the pathophysiology of human liver diseases. An increased rat of apoptosis involving many different mediators, such as Fas, TNF-alpha, TGF-beta 1, and members of the Bcl-2 family is contributing to the liver injury seen in a variety of diseases, including viral hepatitis, cholestatic disorders, and alcoholic liver disease. A reduction of apoptosis should therefore be beneficial in these diseases and the goal for future drug development. On the other hand, dysregulation of apoptotic processes protects malignant hepatocytes from cellular suicide. Specific induction of apoptosis might therefore be a new option for the prevention and treatment of HCC.

UR - http://www.scopus.com/inward/record.url?scp=0034060334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034060334&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(00)00370-3

DO - 10.1016/S0002-9343(00)00370-3

M3 - Article

C2 - 10806286

AN - SCOPUS:0034060334

VL - 108

SP - 567

EP - 574

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 7

ER -